Quote from acrary:
The hottest new category of trading algo's is using immunologic response. It allows the models to become self-adapting and completely autonomous tradebots. Within 5 years I expect these bot's to be better than any human trader ala "Big Blue" in Chess.
I agree with you.
My choice of colleague for writing on trading is a PhD immunologist. We have three years of contact in now.
This is not going to lead to anything like botness but it will make it possible for a person to continually accelerate his equity curve.
Getting to sports memory in trading is more a function of the psy of what is "seen" than any "programming". Bio chemicals as they inject themselves into the scene allow a person to focus on what is really going on.
Getting the triggering to be automatic bio chemically engenders the focus required to ace situations of high potential.
Our approach has been to interview me for hours and hours. It resembles what, I am told, is going on as programmers team to find coding fixes for unusual opportunities.
The logs I recommend to others at this point are arranged to facilitate sequencing the bio chemical and thinking scenarios.
I'm sure the same stuff on a big league scale is possible in terms of getting the machinery to focus on the right stuff to make most money. Steering the machines in the right direction, first, is a key.
In the end, machines will be very helpful, but usually it takes an unexpected turn of events to get to the breakthrough.
We were both contributors to pathology studies where improvements were being sought as a consequence of applying engineering to hospital treatment regimes. The "how do you think about that?" was what led to the above. I just threw in an example of a market situation: "Greenspanning". A lot of immumology relates to imbalances in the human systems; a lack of ability to generate what is needed when it is needed. The mind factory is important in this. That is our mutual focus.